Opioid induces increased DNA damage in prefrontal cortex and nucleus accumbens
Yunwanbin Wang1, Archana Singh1, Guohui Li2
1Department of Pharmacology & Toxicology, School of Pharmacy, University of Kansas, Lawrence, KS, USA.
Pharmacology, Biochemistry, and Behavior
|March 12, 2023
Summary
DNA damage in the brain is linked to opioid use disorder relapse. Reducing this damage with N-acetylcysteine attenuated heroin-seeking behavior in mice, suggesting a new therapeutic target for addiction.
Area of Science:
- Neuroscience
- Molecular Biology
- Addiction Research
Background:
- Opioid use disorder (OUD) affects millions globally, with high relapse rates posing a significant treatment challenge.
- The precise cellular and molecular mechanisms driving relapse in OUD remain largely unknown.
- Emerging evidence links DNA damage and repair pathways to neurodegenerative diseases and substance use disorders.
Purpose of the Study:
- To investigate the relationship between DNA damage and relapse to heroin seeking in opioid use disorder.
- To examine DNA damage levels in the prefrontal cortex (PFC) and nucleus accumbens (NAc) following heroin exposure.
- To determine if manipulating DNA damage can influence heroin-seeking behavior.
Main Methods:
- Analysis of postmortem brain tissues from OUD individuals and healthy controls.
- Assessment of DNA damage in PFC and NAc of mice undergoing heroin self-administration.
- Evaluation of DNA damage persistence during abstinence and the effects of ROS scavenger N-acetylcysteine.
- Pharmacological manipulation of DNA damage using topotecan and etoposide in the PFC.
Main Results:
- Increased DNA damage observed in postmortem PFC and NAc from OUD patients.
- Elevated DNA damage found in the dorsomedial PFC (dmPFC) and NAc of mice after heroin self-administration.
- Persistent DNA damage in mouse dmPFC during abstinence, ameliorated by N-acetylcysteine, correlating with reduced heroin seeking.
- Induction of DNA breaks in the PFC during abstinence potentiated heroin-seeking behavior.
Conclusions:
- Opioid use disorder is associated with accumulated DNA damage in brain regions, particularly the PFC.
- Persistent DNA damage in the PFC may play a crucial role in opioid relapse.
- Targeting DNA damage pathways, potentially via ROS scavenging, could offer novel therapeutic strategies for OUD relapse prevention.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
363
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
363
Analgesia and Pain Management
701
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
701
Opioid Receptors: Overview
1.3K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.3K
Drug Abuse and Addiction: Pharmacological Phenomena
589
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
589
Opioid Analgesics: Morphine and Other Natural Cogeners
315
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
315
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
303
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
303


